Does religiosity in persons with schizophrenia influence medication adherence.

Area of Science:

• Psychiatry
• Clinical Psychology
• Medical Sociology

Background:

• Limited data exists on the influence of religiosity and spirituality on medication adherence in schizophrenia.
• Schizophrenia treatment often involves long-term medication, making adherence a critical factor for patient outcomes.

Purpose of the Study:

• To investigate the association between various dimensions of religiosity and spirituality and medication adherence.
• To explore how different facets of religious and spiritual beliefs impact compliance in schizophrenia patients.

Main Methods:

• A cohort of 100 schizophrenia patients participated in the study.
• Evaluations included standardized scales for religiosity (Religiousness Measure Scale, Duke Religion Index [DUREL]), religious coping (Brief Religious Coping Scale [Brief RCOPE]), quality of life (WHO Quality of Life Spirituality, Religiosity, and Personal Beliefs [WHOQoL-SRPB]), and medication adherence (Brief Adherence Rating Scale [BARS]).

Main Results:

• Increased religiosity, intrinsic religiosity, positive religious coping, and all domains of WHOQoL-SRPB were linked to better medication compliance.
• Medication compliance was measured by the percentage of medication doses consumed in the past month using BARS.

Conclusions:

• Elevated levels of religiosity and spirituality are associated with improved medication compliance in patients with schizophrenia.
• Findings suggest that religious and spiritual factors may play a supportive role in schizophrenia management.